These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37292958)

  • 21. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
    Bergman H; Buckley BS; Villanueva G; Petkovic J; Garritty C; Lutje V; Riveros-Balta AX; Low N; Henschke N
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31755549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pay-it-forward influenza vaccination among older adults and children: A cost-effectiveness analysis in China.
    Tang FF; Kosana P; Jit M; Terris-Prestholt F; Wu D; Ong JJ; Tucker JD
    PLOS Glob Public Health; 2023; 3(8):e0001590. PubMed ID: 37651349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of grade 8 girls.
    Smith LM; Brassard P; Kwong JC; Deeks SL; Ellis AK; Lévesque LE
    BMC Public Health; 2011 Aug; 11():645. PubMed ID: 21838921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-Response Relationship of a Web-Based Tailored Intervention Promoting Human Papillomavirus Vaccination: Process Evaluation of a Randomized Controlled Trial.
    Pot M; Paulussen TG; Ruiter RA; Mollema L; Hofstra M; Van Keulen HM
    J Med Internet Res; 2020 Jul; 22(7):e14822. PubMed ID: 32520718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study.
    Sankaranarayanan R; Prabhu PR; Pawlita M; Gheit T; Bhatla N; Muwonge R; Nene BM; Esmy PO; Joshi S; Poli UR; Jivarajani P; Verma Y; Zomawia E; Siddiqi M; Shastri SS; Jayant K; Malvi SG; Lucas E; Michel A; Butt J; Vijayamma JM; Sankaran S; Kannan TP; Varghese R; Divate U; Thomas S; Joshi G; Willhauck-Fleckenstein M; Waterboer T; Müller M; Sehr P; Hingmire S; Kriplani A; Mishra G; Pimple S; Jadhav R; Sauvaget C; Tommasino M; Pillai MR;
    Lancet Oncol; 2016 Jan; 17(1):67-77. PubMed ID: 26652797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010.
    Laz TH; Rahman M; Berenson AB
    Vaccine; 2012 May; 30(24):3534-40. PubMed ID: 22480927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Willingness and hesitancy towards the governmental free human papillomavirus vaccination among parents of eligible adolescent girls in Shenzhen, Southern China.
    Wu D; Liu P; Wang H; Wan W; Wang Y
    BMC Womens Health; 2024 Apr; 24(1):253. PubMed ID: 38654200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial.
    Baisley K; Kemp TJ; Kreimer AR; Basu P; Changalucha J; Hildesheim A; Porras C; Whitworth H; Herrero R; Lacey CJ; Schiller JT; Lucas E; Mutani P; Dillner J; Indangasi J; Muwonge R; Hayes RJ; Pinto LA; Watson-Jones D
    Lancet Glob Health; 2022 Oct; 10(10):e1485-e1493. PubMed ID: 36113532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discrepancy of human papillomavirus vaccine uptake and intent between girls 9-14 and their mothers in a pilot region of Shanghai, China.
    Guo Q; Zhou W; Wen X; Lu J; Lu X; Lu Y
    Hum Vaccin Immunother; 2022 Nov; 18(6):2132801. PubMed ID: 36306482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I).
    Lehtinen M; Söderlund-Strand A; Vänskä S; Luostarinen T; Eriksson T; Natunen K; Apter D; Baussano I; Harjula K; Hokkanen M; Kuortti M; Palmroth J; Petäjä T; Pukkala E; Rekonen S; Siitari-Mattila M; Surcel HM; Tuomivaara L; Paavonen J; Dillner J; Dubin G; Garnett G
    Int J Cancer; 2018 Mar; 142(5):949-958. PubMed ID: 29055031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial.
    Barnabas RV; Brown ER; Onono M; Bukusi EA; Njoroge B; Winer RL; Donnell D; Galloway D; Cherne S; Heller K; Leingang H; Morrison S; Rechkina E; McClelland RS; Baeten JM; Celum C; Mugo N;
    Trials; 2021 Sep; 22(1):661. PubMed ID: 34579786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV vaccination coverage in three districts in Zimbabwe following national introduction of 0,12 month schedule among 10 to 14 year old girls.
    LaMontagne DS; Manangazira P; Marembo J; Chigodo C; Zvamashakwe C; Tshuma E; Marima E; Chindedza K; Ndlela E; Mooney J
    Vaccine; 2022 Mar; 40 Suppl 1():A58-A66. PubMed ID: 34275674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interventions to improve human papillomavirus vaccination among Chinese female college students: study protocol for a randomized controlled trial.
    Si M; Su X; Jiang Y; Qiao Y; Liu Y
    BMC Public Health; 2019 Nov; 19(1):1546. PubMed ID: 31752785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Training Pediatric Clinicians in Human Papillomavirus Communication Strategies on Human Papillomavirus Vaccination Rates: A Cluster Randomized Clinical Trial.
    Szilagyi PG; Humiston SG; Stephens-Shields AJ; Localio R; Breck A; Kelly MK; Wright M; Grundmeier RW; Albertin C; Shone LP; Steffes J; Rand CM; Hannan C; Abney DE; McFarland G; Kominski GF; Seixas BV; Fiks AG
    JAMA Pediatr; 2021 Sep; 175(9):901-910. PubMed ID: 34028494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination: A Cluster Randomized Clinical Trial.
    Dempsey AF; Pyrznawoski J; Lockhart S; Barnard J; Campagna EJ; Garrett K; Fisher A; Dickinson LM; O'Leary ST
    JAMA Pediatr; 2018 May; 172(5):e180016. PubMed ID: 29507952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II).
    Gray P; Palmroth J; Luostarinen T; Apter D; Dubin G; Garnett G; Eriksson T; Natunen K; Merikukka M; Pimenoff V; Söderlund-Strand A; Vänskä S; Paavonen J; Pukkala E; Dillner J; Lehtinen M
    Int J Cancer; 2018 Jun; 142(12):2491-2500. PubMed ID: 29377141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda.
    Patrick L; Bakeera-Kitaka S; Rujumba J; Malande OO
    PLoS One; 2022; 17(6):e0269655. PubMed ID: 35679304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial.
    Lehtinen M; Apter D; Baussano I; Eriksson T; Natunen K; Paavonen J; Vänskä S; Bi D; David MP; Datta S; Struyf F; Jenkins D; Pukkala E; Garnett G; Dubin G
    Vaccine; 2015 Mar; 33(10):1284-90. PubMed ID: 25593103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.